LumiraDx Inc Respiratory Test Reader LumiraDx™ CLIA Waived - Each - L001000330001-EA
LumiraDx Inc Respiratory Test Reader LumiraDx™ CLIA Waived - Each - L001000330001-EA
Regular price
$6,211.99
Sale price
$6,211.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
LumiraDx Inc Respiratory Test Reader LumiraDx™ CLIA Waived
| Item Id | 1198202 |
| MF Id# | L001000330001 |
| Brand | LumiraDx™ |
| Manufacturer | LumiraDx Inc |
| Country of Origin | Unknown |
| Analyzer Type | Benchtop |
| Application | Respiratory Test Reader |
| CLIA Classified | CLIA Waived |
| Dimensions | 73 X 97 X 210 mm |
| For Use With | For use with LumiraDx Test Strips / LumiraDx Connect |
| Is_Active_Vendor | Y |
| Is_DSCSA | N |
| Is_Discontinued | N |
| Is_Medical_Device | N |
| Lot_Tracking_Flag | N |
| On_Allocation | N |
| Power Source | 100 to 240V, 50/60Hz |
| Purchase Program Type | Standard Purchase Agreement |
| Readout Type | Touchscreen Display |
| Sample Type | Capillary Blood Sample / Nasal Swab Sample |
| Supplier_ID | 67246160 |
| Test Name | SARS-CoV-2 Ag, SARS-CoV-2 Ab, D-Dimer, Prothrombin Time (INR), Surveillance |
| UNSPSC Code | 41115819 |
| User Interface | High Contrast Touch Screen / Barcode Scanner |
| Weight | 2.42 lbs. |
Features
- The LumiraDx Platform is an innovative, next generation point of care system that combines a small, portable instrument, advanced low cost test strip and seamless digital connectivity
- Enzyme and immunoassay on a single platform
- Its proprietary technology enables it to deliver exceptional point of care clinical performance, while being simple and easy to use
- Performance referenced to laboratory test
- Portable instrument, seamless connectivit
- One simple, intuitive test workfow
- Fast results in minutes
- All common clinical samples
- Small sample size including capillary blood
- Ability to perform Quality Control Tests using LumiraDx Quality Control to meet regulatory compliance requirements
- 2 x USB ports, RFID reader 13.56 MHz, 0 dBi (EIRP), Bluetooth low-energy 2.4 GHz ISM band, 2400 MHz to 2483.5 MHz, 0.5 dBm (ERP)
- Lithium ion polymer 7.4 V 5000 mAh battery
- High contrast touchscreen with a wide viewing angle
- Uses small sample volumes and multiple convenient sample types, including nasal swab and capillary blood
- Pipeline of 30+ assays, initially focused on some of the most common conditions being diagnosed or managed with POC testing
- The LumiraDx SARS-CoV-2 Ag Test has been authorized by FDA under an EUA only for the detection of SARS-CoV-2 nucleocapsid protein
- The LumiraDx SARS-CoV-2 Ab Test has been authorized by FDA under an EUA only for detecting the presence of total antibodies to SARS-CoV-2